In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST

• Main Authors: Mahnaz Fatahinia (Author), Marzieh Halvaeizadeh (Author), Ali Zarei Mahmoudabadi (Author), Elham AboualiGalehdari (Author), Neda Kiasat (Author)
• Formato: Livro
• Publicado em: Mazandaran University of Medical Sciences, 2020-06-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

<strong>Background and Purpose:</strong> Candida glabrata is the second cause of candidiasis. The mortality rate of C. glabrata infections is about 40%; accordingly, it may be life threatening, especially in immunocompromised hosts. Regarding this, the current study was conducted to eval...